ArticlePeerJ2021

TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer.

Jia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.